Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03698149 · ClinicalTrials.gov registry record · NA
ECoG BMI for Motor and Speech Control
A NA study of Stroke and Multiple Sclerosis, sponsored by Karunesh Ganguly.
- Recruiting
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT03698149: Recruiting NA study of Stroke and Multiple Sclerosis, sponsored by Karunesh Ganguly.
NCT03698149 is a NA study of Stroke and Multiple Sclerosis that is actively recruiting participants, run by Karunesh Ganguly. The registered enrollment target is 3 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03698149, a NA study of Stroke and Multiple Sclerosis, is actively recruiting participants, sponsored by Karunesh Ganguly.
- RECRUITING
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.
Primary Outcome
The primary endpoint of this study is to determine the incidence of treatment-emergent adverse events associated with the ECoG-based interface
Conditions Studied
Interventions
- DEVICE PMT/Blackrock Combination Device
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-11-09 |
| Est. Completion | 2030-08-15 |
| Phase | NA |
What NCT03698149 shows while recruiting
NCT03698149 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which PMT/Blackrock Combination Device is the first listed.
NCT03698149 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03698149 about?
NCT03698149 is a clinical study titled "ECoG BMI for Motor and Speech Control". Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.
What is the current status of trial NCT03698149?
This trial is currently recruiting. It is a NA study. The enrollment target is 3 participants. The study started on 2018-11-09. Estimated completion is 2030-08-15.
What conditions does trial NCT03698149 study?
This clinical trial studies the following conditions: Stroke, Multiple Sclerosis, ALS, SCI - Spinal Cord Injury, Muscular Dystrophies.
What interventions are being tested in trial NCT03698149?
The interventions under investigation include: PMT/Blackrock Combination Device (DEVICE).
Who is sponsoring clinical trial NCT03698149?
This trial is sponsored by Karunesh Ganguly, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03698149 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03698149's enrollment target sits among peer trials
3 448th of 454 higher than 2 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI